Lianxin Liu

Tumour-associated mutant p53 drives the Warburg effect

Cen Zhang, Juan Liu, Yingjian Liang et al. · Nature Communications · 2013 · 433 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +14

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

Yingjian Liang, Tongsen Zheng, Ruipeng Song et al. · Hepatology · 2013 · 293 citations

Medicine, Oncology, Pharmacology +16

Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation

Xirui Liu, Yingjian Liang, Ruipeng Song et al. · Molecular Cancer · 2018 · 264 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma

Ruiqi Liu, Yuejin Li, Lantian Tian et al. · Cancer Letters · 2018 · 144 citations

Medicine, Cancer Biology, Oncology +16

Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways

Baolei Zhao, Yong Ma, Zhilin Xu et al. · Cancer Letters · 2014 · 112 citations

Medicine, Biochemistry, Oncology +12